This inventor holds 4 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Ipsen Biopharm Limited, Merrimack Pharmaceuticals, Inc.. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2016 - 2018)
- Arlington, MA (US) (2022)
- Cambridge, MA (US) (2022)
Company Filing History:
Years Active: 2016-2022
Title: The Innovative Contributions of Inventor Helen Lee
Introduction
Helen Lee, an accomplished inventor based in Arlington, MA, has made significant strides in the field of cancer treatment, amassing a total of four patents. Her groundbreaking work focuses on combination therapies that aim to improve outcomes for patients diagnosed with challenging forms of cancer.
Latest Patents
One of Helen’s latest innovations is a patent for methods of treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin. This combination regimen also includes the administration of leucovorin and 5-fluorouracil every two weeks, proving useful for patients diagnosed with untreated metastatic adenocarcinoma of the pancreas. Additionally, she holds a patent for nanoliposomal irinotecan, which is intended for use in treating small cell lung cancer. This novel therapy consists of administering liposomal irinotecan every two weeks, often combined with other non-antineoplastic agents such as corticosteroids and anti-emetics prior to treatment.
Career Highlights
Helen has lent her expertise to prominent companies in the pharmaceutical industry, notably Merrimack Pharmaceuticals and Ipsen Biopharm Limited. Her contributions have had a considerable impact on the development of effective cancer treatments, reflecting her dedication to improving patient care and outcomes.
Collaborations
Throughout her career, Helen has worked alongside esteemed colleagues, including Bart S. Hendriks and Daniel F. Gaddy. Their collaborations have fostered innovative advancements in cancer therapies, enhancing the efficacy of treatments and expanding the available options for patients facing serious health challenges.
Conclusion
Helen Lee’s contributions as an inventor and innovator in the field of cancer treatment have made her a notable figure in the pharmaceutical landscape. With her pioneering patents and collaborative efforts, she continues to play a crucial role in advancing medical science and improving the lives of patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile